|
Call Invite Details: Who: Dennis Grimaud, CEO of RED Consulting and Former CEO and Co-founder of DIATHERIX Laboratories When: Tuesday, March 10 at 3:15PM ET Where: Audio Only: Participating Dialing Instructions Toll Free: Toll: UK: 0 Confirmation Number: 13700019 |
Details. We hope you can join us for what promises to be a very interesting conference call with Dennis Grimaud, the Co-Founder and former CEO of DIATHERIX Laboratories. DIATHERIX, which has been acquired by Eurofins, is a leader in the development of diagnostic tools to aid in the identification and treatment of viral disease including H1N1 and a host of coronavirus.
Dennis, Tom Tobin and I will discuss those topics which have been top of mind as investors try and assess the impact of COVID-19 testing, diagnosis and treatment, including:
- What may have gone wrong in China and how that impacted mortality rates
- Mis-steps by US in containment and the implications for the spread of disease
- At-risk populations and complications that may give rise to hospitalizations or not.
- Rate if Change in Testing v Rate of Change in Disease Spread
- Regional hotspots or national impact
Please call if you have any questions and we look forward to you joining us next week.
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
